BusinessPostCorner.com
No Result
View All Result
Sunday, June 1, 2025
  • Home
  • Business
  • Finance
  • Accounting
  • Tax
  • Management
  • Marketing
  • Crypto News
  • Human Resources
BusinessPostCorner.com
  • Home
  • Business
  • Finance
  • Accounting
  • Tax
  • Management
  • Marketing
  • Crypto News
  • Human Resources
No Result
View All Result
BusinessPostCorner.com
No Result
View All Result

Diet drug Wegovy has with a big added benefit, study finds

May 19, 2023
in Business
Reading Time: 2 mins read
A A
0
Diet drug Wegovy has with a big added benefit, study finds
ShareShareShareShareShare

Patients who took the diet drug Wegovy for a year had a reduced risk of heart disease in an early hint that Novo Nordisk’s best-selling obesity medicine may also have a positive impact on cardiovascular health.

People followed in a study saw their 10-year risk of cardiovascular disease decline by 18%, said Andres Acosta, an associate professor of medicine at the Mayo Clinic. Researchers used a standardized survey of heart risk to assess about 100 people, mostly White women, who took Wegovy over the course of a year at clinic sites around the US. 

The study took place in the real world rather than a clinical trial, meaning there was no control group, so researchers couldn’t say for sure whether the improvement was due to Wegovy, known generically as semaglutide, or whether other factors could have been at play. But the outcome is a positive sign as doctors await results from a larger, more rigorous trial being run by Novo, Acosta said in an interview. 

The results are “a great sign that the Select trials that are ongoing for cardiovascular overall mortality hopefully will be successful,” Acosta said in an interview, using the name assigned to Novo’s study. “But we need to wait for those studies.” He presented the findings at the European Congress on Obesity in Dublin.

The larger trial follows 17,500 patients with obesity and a history of cardiovascular disease, and its results are due this summer.  

Though the much smaller Mayo Clinic study wasn’t randomized, its authors did observe positive impacts on blood pressure, blood sugar level and liver function and less use of other drugs, said Grace O’Malley, leader of the Obesity Research and Care Group at Ireland’s RCSI University of Medicine and Health Science, who wasn’t involved with the trial. 

Uncontrollable Vomiting

Hearing about “outcomes other than body weight alone” is crucial, O’Malley said, noting the frequency of side effects. “Access to obesity medicines should be protected for those with complications related to obesity and should not be used in an attempt to change body size for aesthetic reasons.”

The Mayo Clinic team also looked at the weight patients shed and at side effects. Weight loss averaged around 13% of body weight among about 300 patients the group followed, mirroring what had been seen in randomized clinical trials. About half experienced side effects, mostly nausea, as well as diarrhea, abdominal pain and constipation.

As many as 5% of the Wegovy patients required hospitalization or a visit to the emergency room due to severe side effects, a larger number than had been seen in clinical trials, according to Acosta. The hospital visits were a result of patients becoming dehydrated due to uncontrollable nausea and vomiting, he said, a sign that doctors will need to monitor patients closely as weight-loss drugs are more widely prescribed.   

The real-world trial mirrored the constrictions on supply that patients with obesity are experiencing. The clinic’s doctors had prescribed the drug to about 1,000 people, but only about 300 were able to start taking it, Acosta said. Patients had difficulty accessing the medicine because of shortages as well as a lack of insurance coverage.

Credit: Source link

ShareTweetSendPinShare
Previous Post

Intel CEO Pat Gelsinger, Accessibility Boss Darryl Adams Talk Building Hearing Health Tech And More In Interview

Next Post

US debt ceiling talks poised to resume after pause

Next Post
US debt ceiling talks poised to resume after pause

US debt ceiling talks poised to resume after pause

To succeed at succession, ask yourself these hard questions

To succeed at succession, ask yourself these hard questions

May 29, 2025
Memorial Day 2025: What stores are open and closed?

Memorial Day 2025: What stores are open and closed?

May 26, 2025
When tech fails, accountants prevail

When tech fails, accountants prevail

May 27, 2025
High school students are totally behind and addicted to their phones—it’s making teachers crazy and driving them to quit

High school students are totally behind and addicted to their phones—it’s making teachers crazy and driving them to quit

May 25, 2025
KFC to create 7,000 jobs in UK and Irish growth plan

KFC to create 7,000 jobs in UK and Irish growth plan

May 27, 2025
Bitcoin Price Prediction: Post-7M Liquidation Carnage – Can BTC Reclaim 4k Amid ETF Inflows?

Bitcoin Price Prediction: Post-$827M Liquidation Carnage – Can BTC Reclaim $104k Amid ETF Inflows?

May 31, 2025
BusinessPostCorner.com

BusinessPostCorner.com is an online news portal that aims to share the latest news about following topics: Accounting, Tax, Business, Finance, Crypto, Management, Human resources and Marketing. Feel free to get in touch with us!

Recent News

How Iran is preparing for Israeli or US strikes

How Iran is preparing for Israeli or US strikes

June 1, 2025
Tough choices unavoidable, says IFS

Tough choices unavoidable, says IFS

May 31, 2025

Our Newsletter!

Loading
  • Contact Us
  • Privacy Policy
  • Terms of Use
  • DMCA

© 2023 businesspostcorner.com - All Rights Reserved!

No Result
View All Result
  • Home
  • Business
  • Finance
  • Accounting
  • Tax
  • Management
  • Marketing
  • Crypto News
  • Human Resources

© 2023 businesspostcorner.com - All Rights Reserved!